Abstract
Ski is an oncoprotein that represses transforming growth factor-β and nuclear receptor signaling. Despite evidence that relates increased Ski protein levels directly with tumor progression in human cells, the signaling pathways that regulate Ski expression are mostly unidentified. Here we show that the Ski protein levels vary throughout the cell cycle, being lowest at G0/G1. This reduction in Ski protein levels results from proteosomal degradation as suggested by in vivo ubiquitination of Ski and the effects of proteosomal inhibitors. In contrast, an upregulation of the Ski protein was observed in cells going through mitosis. At this stage, we also found that Ski is phosphorylated. In vitro and in vivo data suggest that the phosphorylation of Ski in mitosis is carried out by the main kinase controlling the progression of mitosis, namely cdc2/cyclinB. Interestingly, immunofluorescence experiments, supported by biochemical data, show not only an increase in the Ski protein levels, but also a dramatic redistribution of Ski to the centrosomes and mitotic spindle throughout mitosis. Studies to date on Ski have focused on its role as a transcriptional regulator. However, Ski's increased level and specific relocalization during mitosis suggest that Ski might play a distinct role during this particular phase of the cell cycle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- TGF-β:
-
transforming growth factor-β
- cdk:
-
cyclin-dependent kinase
- DAPI:
-
4,6-diamidino-2-phenylindole
- SB:
-
sample buffer.
References
Ambrose MR, Bottazzi ME and Goodenow MM . (1995). DNA Cell Biol., 14, 701–707.
Benezra R, Rafii S and Lyden D . (2001). Oncogene, 20, 8334–8341.
Blomberg-Wirschell M and Doxsey SJ . (1998). Methods Enzymol., 298, 228–238.
Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K and Wrana JL . (2001). Nat. Cell. Biol., 3, 587–595.
Buess M, Terracciano L, Reuter J, Ballabeni P, Boulay JL, Laffer U, Metzger U, Herrmann R and Rochlitz C . (2004). Neoplasia, 6, 207–212.
Colmenares C and Stavnezer E . (1989). Cell, 59, 293–303.
Colmenares C, Sutrave P, Hughes SH and Stavnezer E . (1991). J. Virol., 65, 4929–4935.
Dahl R, Kieslinger M, Beug H and Hayman MJ . (1998). Proc. Natl. Acad. Sci. USA, 95, 11187–11192.
De Lucia F, Lorain S, Scamps C, Galisson F, MacHold J and Lipinski M . (2001). Biochem. J., 358, 447–455.
Doxsey S . (2001). Nat. Rev. Mol. Cell. Biol., 2, 688–698.
Faust M, Gunther J, Morgenstern E, Montenarh M and Gotz C . (2002). Cell Mol. Life Sci., 59, 2155–2164.
Fukuchi M, Nakajima M, Fukai Y, Miyazaki T, Masuda N, Sohda M, Manda R, Tsukada K, Kato H and Kuwano H . (2004). Int. J. Cancer, 108, 818–824.
Fumagalli S, Doneda L, Nomura N and Larizza L . (1993). Melanoma Res., 3, 23–27.
Grimes HL, Ambrose MR and Goodenow MM . (1993). Oncogene, 8, 2863–2868.
Hasskarl J, Duensing S, Manuel E and Munger K . (2004). Oncogene, 23, 1930–1938.
King RW, Deshaies RJ, Peters JM and Kirschner MW . (1996). Science, 274, 1652–1659.
Li G, Nelsen C and Hendrickson EA . (2002). Proc. Natl. Acad. Sci. USA, 99, 832–837.
Li Y, Turck CM, Teumer JK and Stavnezer E . (1986). J. Virol., 57, 1065–1072.
Liu X, Sun Y, Weinberg RA and Lodish HF . (2001). Cytokine Growth Factor Rev., 12, 1–8.
Macdonald M, Wan Y, Wang W, Roberts E, Cheung TH, Erickson R, Knuesel MT and Liu X . (2004). Oncogene, 23, 5643–5653.
Maruyama H, Kleeff J, Wildi S, Friess H, Buchler MW, Israel MA and Korc M . (1999). Am. J. Pathol., 155, 815–822.
Medrano EE . (2003). Oncogene, 22, 3123–3129.
Meijer L and Raymond E . (2003). Acc. Chem. Res., 36, 417–425.
Nagase T, Nomura N and Ishii S . (1993). J. Biol. Chem., 268, 13710–13716.
Nigg EA . (2001). Nat. Rev. Mol. Cell. Biol., 2, 21–32.
Nomura N, Sasamoto S, Ishii S, Date T, Matsui M and Ishizaki R . (1989). Nucleic Acids Res., 17, 5489–5500.
Nomura T, Khan MM, Kaul SC, Dong HD, Wadhwa R, Colmenares C, Kohno I and Ishii S . (1999). Genes Dev., 13, 412–423.
Reed JA, Bales E, Xu W, Okan NA, Bandyopadhyay D and Medrano EE . (2001). Cancer Res., 61, 8074–8078.
Rieder CL, Faruki S and Khodjakov A . (2001). Trends Cell Biol., 11, 413–419.
Salghetti SE, Kim SY and Tansey WP . (1999). EMBO J., 18, 717–726.
Stavnezer E, Barkas AE, Brennan LA, Brodeur D and Li Y . (1986). J. Virol., 57, 1073–1083.
Stavnezer E, Brodeur D and Brennan LA . (1989). Mol. Cell. Biol., 9, 4038–4045.
Stroschein SL, Bonni S, Wrana JL and Luo K . (2001). Genes Dev., 15, 2822–2836.
Sun Y, Liu X, Ng-Eaton E, Lodish HF and Weinberg RA . (1999). Proc. Natl. Acad. Sci. USA, 96, 12442–12447.
Sutrave P, Copeland TD, Showalter SD and Hughes SH . (1990). Mol. Cell. Biol., 10, 3137–3144.
Ueki N and Hayman MJ . (2003). J. Biol. Chem., 278, 24858–24864.
Wan Y, Liu X and Kirschner MW . (2001). Mol. Cell, 8, 1027–1039.
Wang W, Mariani FV, Harland RM and Luo K . (2000). Proc. Natl. Acad. Sci. USA, 97, 14394–14399.
Wu JW, Krawitz AR, Chai J, Li W, Zhang F, Luo K and Shi Y . (2002). Cell, 111, 357–367.
Xu W, Angelis K, Danielpour D, Haddad MM, Bischof O, Campisi J, Stavnezer E and Medrano EE . (2000). Proc. Natl. Acad. Sci. USA, 97, 5924–5929.
Yang R, Muller C, Huynh V, Fung YK, Yee AS and Koeffler HP . (1999). Mol. Cell. Biol., 19, 2400–2407.
Acknowledgements
We would like to thank Drs Nobuhide Ueki and Ricardo Armisén for help with the discussion of the manuscript and technical advice. We are grateful to Drs Gail Mandel and Patrick Hearing for allowing us to use their laboratory facilities and Dr Clemencia Colmenares for providing us with ski−/− MEFs. This work was supported by U.S. Public Health Service Grant CA42573 from the National Cancer Institute.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marcelain, K., Hayman, M. The Ski oncoprotein is upregulated and localized at the centrosomes and mitotic spindle during mitosis. Oncogene 24, 4321–4329 (2005). https://doi.org/10.1038/sj.onc.1208631
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208631
Keywords
This article is cited by
-
Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease
Signal Transduction and Targeted Therapy (2018)
-
c-Ski in health and disease
Cell and Tissue Research (2012)
-
Ski and SnoN, potent negative regulators of TGF-β signaling
Cell Research (2009)